CTRI Number |
CTRI/2023/05/053041 [Registered on: 23/05/2023] Trial Registered Prospectively |
Last Modified On: |
22/05/2023 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
ayurvedic aetiopathogenesis of amavata with therapeutic effect of pathyadi churna |
Scientific Title of Study
|
Nidanpanchatamak Study Of Amavata [Rheumatoid Arthritis] With Upasayatmaka Effect Of Pathyadi Churna w.s.r. To Biological Marker |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Ashu |
Designation |
Ph.D. Scholar |
Affiliation |
Guru Ravidas Ayurved University Punjab |
Address |
Vaidya Yagya Dutt Sharama Ayurvedic College Khurja Bulandshahar Guru Ravidas Ayurved University VPO Kharkan Una Road Hoshiarpur Punjab Bulandshahar UTTAR PRADESH 203131 India |
Phone |
9318809011 |
Fax |
|
Email |
dr.ashu007@yahoo.com |
|
Details of Contact Person Scientific Query
|
Name |
vaidya Rakesh Sharma |
Designation |
Professor |
Affiliation |
Guru Ravidas Ayurved University Punjab |
Address |
President of BERISM
National Commission of Indian System of Medicine 61-65 Institutional Area Janak Puri Delhi Guru Ravidas Ayurved University VPO Kharkan Una Road Hoshiarpur Punjab West DELHI 110058 India |
Phone |
9814779242 |
Fax |
|
Email |
president.berism@ncismindia.org |
|
Details of Contact Person Public Query
|
Name |
Dr Ashu |
Designation |
Ph.D. Scholar |
Affiliation |
Guru Ravidas Ayurved University Punjab |
Address |
Vaidya Yagya Dutt Sharama Ayurvedic College Khurja Bulandshahar Guru Ravidas Ayurved University VPO Kharkan Una Road Hoshiarpur Punjab Bulandshahar UTTAR PRADESH 203131 India |
Phone |
9318809011 |
Fax |
|
Email |
dr.ashu007@yahoo.com |
|
Source of Monetary or Material Support
|
Vaidya Yagya Dutt Sharma Ayurved College Khurja District Bulandshahar UP 203131 |
|
Primary Sponsor
|
Name |
Dr Ashu |
Address |
Vaidya Yagya Dutt Sharma Ayurvedic College Khurja Bulandshshar |
Type of Sponsor |
Other [SELF] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Ashu |
Dept. Of Rog Nidan and Vikriti Vigyan Vaidya Yagya Dutt Sharma Ayurved College |
Dharpa GT Road Khurja Dist. Bulandshahar Bulandshahar UTTAR PRADESH |
9318809011
dr.ashu007@yahoo.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethical Committee Guru Ravidas Ayurved University Hoshiarpur Punjab and VYDS Ayurved College Khurja |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:M057||Rheumatoid arthritis with rheumatoid factor without organ or systems involvement. Ayurveda Condition: AMAVATAH, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Pathyadi Churna, Reference: Bhava Praksaha Amavata Chikitsa 26-37-38, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Luke warm water), Additional Information: - |
|
|
Inclusion Criteria
|
Age From |
20.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
1. Angamardha, Aruchi, Trishna, Alasya, Gaurava, Jwara, Apaka, Sandhi Shotha, and 2010 ACR-EULAR classification criteria for Rheumatoid Arthritis.
2. Subjects aged between 20-60 years
3. Subjects of either gender
4. Subjects willing to participate in the study and ready to sign informed consent form. |
|
ExclusionCriteria |
Details |
1. Subjects with known case of essential hypertension and uncontrolled diabetes mellitus
2. Subjects with known case of impaired renal, hepatic and cardiac function
3. Subjects with known case of systemic arthritis (gout, tubercular arthritis, systemic lupus erythematosus, psoriatic arthritis)
4. Pregnant and Lactating women.
|
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Case Record Numbers |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
A joint involvement (0–5 points)
1 large joint 0
2–10 large joints 1
1–3 small joints 2
4–10 small joints 3
10 joints including at least one small joint 5
B Serology 0–3 points
Negative RF and negative ACPA 0
Low positive RF or low positive ACPA 2
High positive RF or high positive ACPA 3
C Acute-phase reactants 0–1 point
Normal CRP and normal ESR 0
Abnormal CRP or abnormal ESR 1
D Duration of symptomsed
6 weeks 0
≥6 weeks 1 |
30 days
|
|
Secondary Outcome
|
Outcome |
TimePoints |
Ayurvedic Assessment parameter
1 Angamarda
2 Aruchi
3 Trishna
4 Alasya
5 Gaurava
6 Jwara
7 Apaka
8 Shotha
|
30 days |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
31/05/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="1" Days="0" |
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
NONE YET |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Introduction: The study is an open label, single arm, prospective
clinical trial in Amavata (Rheumatoid Arthritis) (n=60)
selected using the convenience (non-random) sampling technique with pre and
post design conducted in tertiary Ayurveda Hospital attached to VYDS Ayurveda
Medical College located in district Bulandshahar India, irrespective of caste, sex, occupation and
socio-economic status etc. Diagnostic Criteria : Angamarda, Aruchi, Trishna, Alasya, Gaurava, Jwara, Apaka, Sandhi Shotha, and 2010 ACR-EULAR 114 classification
criteria for Rheumatoid Arthritis with grading score. LABORATORY
INVESTIGATION: ESR, (Hb gm %),Urine Analysis, Serum uric acid level was estimated to rule out the possibility of other pathological conditions. Bio- Markers :Rheumatoid Factor (RF), C- Reactine Protein (CRP). POSOLOGY: Drug- Pathyadi Churna (Bhavaprakash ) 3g BID with Luke warm water For 30 days. FINAL ASSESSMENT OF RESULT: Patients will be assessed before & after the treatment (30 days) for improvement in symptoms on the basis of said scoring pattern & percentage improvement would be calculated.
|